Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality
Phase: PHASE2 | Sponsor: The University of Texas Health Science Center, Houston | Compound: Psilocybin
- Status
- recruiting
- Institution
- The University of Texas Health Science Center, Houston
- Start date
- 2025-07-07
- End date
- 2027-01-01
- Registry ID
- NCT06706232
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.